COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Infectious virus in feces is a common manifestation of COVID-19, according to a study from China published in the Center for Disease Control and Prevention’s Emerging Infectious Diseases journal.
The Food and Drug Administration authorized the emergency use of Everlywell, Inc.’s COVID-19 Test Home Collection Kit.
The Food and Drug Administration authorized the emergency use of infusion pumps to counteract insufficient supplies needed for the continuous infusion of medications, total parenteral nutrition and other fluids into COVID-19 patients.
Based on early data, the Abbott ID NOW point-of-care test to diagnose COVID-19 may return false negative results, the Food and Drug Administration announced, adding that it will continue to review data as the company conducts post-market studies to better understand the cause.
The CDC issued a health advisory warning of COVID-19-associated multisystem inflammatory syndrome in children.
CMS recently issued new guidance to states to allow temporary COVID-19-related modifications in provider payment methodologies and capitation rates under Medicaid managed care plans.
The CDC will award $10.25 billion from the Paycheck Protection Program and Health Care Enhancement Act to states, localities and territories by May 23 to expand COVID-19 testing and surveillance activities, the agency announced.
The Centers for Medicare & Medicaid Services issued new guidance to states to allow temporary COVID-19-related modifications in provider payment methodologies and capitation rates under Medicaid managed care plans. Please see the CMS information bulletin to state Medicaid agencies for details.
The Centers for Medicare & Medicaid released a new toolkit of best practices to help nursing homes, states and departments of health address the COVID-19 crisis within nursing homes.
The Centers for Medicare & Medicaid Services has posted a FAQ on the Coronavirus Aid, Relief, and Economic Security Act requirement that providers of COVID-19 diagnostic tests make public the cash price for the tests on their website during the public health emergency.